These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 7291202

  • 1. Pharmacogenetic interactions in G6PD deficiency and development of an in vitro test to predict a drug's hemolytic potential.
    Magon A, Leipzig RM, Bloom K, Brewer GJ.
    Prog Clin Biol Res; 1981; 55():709-24. PubMed ID: 7291202
    [Abstract] [Full Text] [Related]

  • 2. Interactions of glucose-6-phosphate dehydrogenase deficiency with drug acetylation and hydroxylation reactions.
    Magon AM, Leipzig RM, Zannoni VG, Brewer GJ.
    J Lab Clin Med; 1981 Jun; 97(6):764-70. PubMed ID: 7229511
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Dapsone-induced hemolytic anemia: role of glucose-6-phosphate dehydrogenase in the hemolytic response of rat erythrocytes to N-hydroxydapsone.
    Grossman S, Budinsky R, Jollow D.
    J Pharmacol Exp Ther; 1995 May; 273(2):870-7. PubMed ID: 7752092
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Hemolysis by diphenylsulfones: comparative effects of DDS and hydroxylamine-DDS.
    Glader BE, Conrad ME.
    J Lab Clin Med; 1973 Feb; 81(2):267-72. PubMed ID: 4683425
    [No Abstract] [Full Text] [Related]

  • 9. G6PD-deficiency: a potential high-risk group to copper and chlorite ingestion.
    Moore GS, Calabrese EJ.
    J Environ Pathol Toxicol; 1980 Sep; 4(2-3):271-9. PubMed ID: 7462905
    [Abstract] [Full Text] [Related]

  • 10. Hemolysis and Metabolic Lesion of G6PD Deficient RBCs in Response to Dapsone Hydroxylamine in a Humanized Mouse Model.
    Dziewulska KH, Reisz JA, Hay AM, D'Alessandro A, Zimring JC.
    J Pharmacol Exp Ther; 2023 Sep; 386(3):323-330. PubMed ID: 37348965
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Hemolytic effect of niridazole in G6PD deficiency].
    Coulaud JP, Payet M, Kaplan JC, Ba M.
    Nouv Presse Med; 1976 Nov 27; 5(40):2720-1. PubMed ID: 1005089
    [No Abstract] [Full Text] [Related]

  • 16. Absence of hemolytic effects of L-DOPA on transfused G6PD-deficient erythrocytes.
    Gaetani G, Salvidio E, Pannacciulli I, Ajmar F, Paravidino G.
    Experientia; 1970 Nov 27; 26(7):785-6. PubMed ID: 5431157
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Nature of hemolytic crises and the fate of G6PD deficient, drug-damaged erythrocytes in Sardinians.
    Salvidio E, Pannacciulli I, Tizianello A, Ajmar F.
    N Engl J Med; 1967 Jun 15; 276(24):1339-44. PubMed ID: 6024564
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.